» Articles » PMID: 34552015

Short- and Long-Term Complications of Bronchopulmonary Dysplasia

Overview
Journal Respir Care
Publisher Mary Ann Liebert
Specialty Pulmonary Medicine
Date 2021 Sep 23
PMID 34552015
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Bronchopulmonary dysplasia (BPD) is a chronic lung disease most commonly seen in preterm infants of low birthweight who required postnatal respiratory support. Although overall incidence rates have not changed, recent advancements in medical care have resulted in lower mortality rates, and those affected are beginning to live longer. As a result, the long-term repercussions of BPD are becoming more apparent. Whereas BPD has been thought of as a disease of just the lungs, resulting in abnormalities such as increased susceptibility to pulmonary infections, impaired exercise tolerance, and pulmonary hypertension, the enduring complications of BPD have been found to extend much further. This includes an increased risk for cerebral palsy and developmental delays, lower intelligence quotient (IQ) scores, impaired executive functioning, behavioral challenges, delays in expressive and receptive language development, and an increased risk of growth failure. In addition, the deficits of BPD have been found to influence much more than just physical health; BPD survivors have been noted to have higher rates of health care use, starting with the initial hospitalization and continuing with therapy and specialist follow-up, as well as impairments in quality of life, both physical and psychological, that continue into adulthood. The long-term consequences of BPD may best be addressed through future research, including better understanding of the pathophysiologic mechanisms leading to BPD, further comparisons between newborns with BPD and those without, and long-term assessment and management of BPD patients as adults.

Citing Articles

Human milk and bronchopulmonary dysplasia have a dose-dependent effect: a cohort study.

Yang J, Li J, Wang H, Chen X, Yang C, ChaoMu L BMJ Paediatr Open. 2025; 9(1).

PMID: 39904541 PMC: 11795393. DOI: 10.1136/bmjpo-2024-002727.


[Prognosis of bronchopulmonary dysplasia].

Zhou Y, Wang T, Fu X, Peng B, Fu Z Zhongguo Dang Dai Er Ke Za Zhi. 2025; 27(1):115-120.

PMID: 39825661 PMC: 11750241. DOI: 10.7499/j.issn.1008-8830.2406004.


Perception of quality of life in school-age children born before 32 weeks of gestational age.

Merino-Hernandez A, Munoz-Cutillas A, Ramos-Navarro C, Bellon-Alonso S, Rodriguez-Cimadevilla J, Gonzalez-Pacheco N Eur J Pediatr. 2024; 184(1):49.

PMID: 39604511 DOI: 10.1007/s00431-024-05882-z.


Neonatal multimorbidity and the phenotype of premature aging in preterm infants.

Litt J, Belfort M, Everson T, Haneuse S, Tiemeier H Pediatr Res. 2024; .

PMID: 39455859 DOI: 10.1038/s41390-024-03617-2.


Nintedanib preserves lung growth and prevents pulmonary hypertension in a hyperoxia-induced lung injury model.

Ding K, Smith C, Seedorf G, Abman S Pediatr Res. 2024; .

PMID: 39394424 DOI: 10.1038/s41390-024-03562-0.